Literature DB >> 26755000

Fatal granulomatous amoebic encephalitis caused by Acanthamoeba in a newly diagnosed patient with systemic lupus erythematosus.

Vamshi Krishna Thamtam, Megha S Uppin1, Anjan Pyal, Subhash Kaul, Jyostna Y Rani, C Sundaram.   

Abstract

Granulomatous amoebic encephalitis (GAE) caused by certain species belonging to the genus Acanthamoeba, Balamuthia, or Naegleria presents as a subacute or chronic illness. Amoebic encephalitis caused by Acanthamoeba is seen more often in immunosuppressed individuals. Thus, it may often be associated with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), organ transplantation, administration of steroids and systemic lupus erythematosus (SLE). The clinical progression is rapid, most often leading on to mortality of the patients. The diagnosis in most of these patients is established on postmortem examination. We describe a case of fatal granulomatous amoebic encephalitis in a patient recently diagnosed to be having SLE, who was receiving corticosteroids, cyclophosphamide, methotrexate, and hydroxychloroquine. The patient presented in an altered sensorium and expired after being hospitalized for 6 days. Postmortem examination of the brain showed extensive areas of necrosis and neutrophilic infiltrate with trophozoites and cysts of Acanthamoeba.

Entities:  

Mesh:

Year:  2016        PMID: 26755000     DOI: 10.4103/0028-3886.173662

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  9 in total

1.  In vivo CNS infection model of Acanthamoeba genotype T4: the early stages of infection lack presence of host inflammatory response and are a slow and contact-dependent process.

Authors:  Maritza Omaña-Molina; Dolores Hernandez-Martinez; Raquel Sanchez-Rocha; Ulises Cardenas-Lemus; Citlaltepetl Salinas-Lara; Adolfo Rene Mendez-Cruz; Laura Colin-Barenque; Patricia Aley-Medina; Jesus Espinosa-Villanueva; Leticia Moreno-Fierros; Jacob Lorenzo-Morales
Journal:  Parasitol Res       Date:  2016-12-03       Impact factor: 2.289

Review 2.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

Review 3.  Case Report: First Successful Treatment of Acanthamoeba Brain Abscess with Combination Surgical Excision and Miltefosine-Led Antimicrobial Therapy.

Authors:  Anson Chan; Simon Smith; Edwin Tan; Sarin Kuruvath
Journal:  Am J Trop Med Hyg       Date:  2022-01-17       Impact factor: 3.707

4.  Acanthamoeba encephalitis in immunocompetent hosts: A report of two cases.

Authors:  Sohini Das; Karthik Gunasekaran; Sitara S R Ajjampur; Dilip Abraham; Tina George; M Asisha Janeela; Ramya Iyadurai
Journal:  J Family Med Prim Care       Date:  2020-02-28

5.  Granulomatous Amebic Encephalitis Presenting Like a Tumor-Chasing a Diagnostic Conundrum.

Authors:  Ashok V R Taallapalli; Saraswati Nashi; Girish B Kulkarni; Suvarna Alladi; Yasha T Chickabasaviah
Journal:  Ann Indian Acad Neurol       Date:  2021-10-07       Impact factor: 1.383

Review 6.  Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.

Authors:  Tao Ming Sim; Anselm Mak; Sen Hee Tay
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

7.  Pathogenic Acanthamoeba T4 Genotype Isolated from Mucosal Tissue of a Patient with HIV Infection: A Case Report.

Authors:  Fatemeh Memari; Maryam Niyyati; Zeynab Joneidi
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

8.  Balamuthia mandrillaris infection in China: a retrospective report of 28 cases.

Authors:  Lei Wang; Wenjing Cheng; Bing Li; Zhe Jian; Xianlong Qi; Dongjie Sun; Jian Gao; Xuetao Lu; Yi Yang; Kun Lin; Chuanlong Lu; Jiaxi Chen; Chunying Li; Gang Wang; Tianwen Gao
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 9.  Application of Dendrimers for Treating Parasitic Diseases.

Authors:  Veronica Folliero; Carla Zannella; Annalisa Chianese; Debora Stelitano; Annalisa Ambrosino; Anna De Filippis; Marilena Galdiero; Gianluigi Franci; Massimiliano Galdiero
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.